Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Distinct miR Expression Signatures of Primary and Secondary CNS Lymphomas

ABSTRACT: FFPE brain biopsy specimens of 64 patients with primary central nervous system lymphoma and 9 patients with secondary central nervous system lymphoma were analyzed in the study. We used the NanoSting nCounter human v3 miRNA assay for characterizing miRNA expression and carried out a detailed differential expression and clustering analysis of samples and miRNAs to look for expression changes associated to primary or secondary origin, cell of origin, mutation status or survival.

ORGANISM(S): Homo sapiens

PROVIDER: GSE162956 | GEO | 2021/11/29

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

miRNA expression data from primary central nervous system lymphomas (PCNSL)

Project description:miRNA expression data from primary central nervous system lymphomas (PCNSL)

| PRJNA503123 | ENA

miRNA expression data from primary central nervous system lymphomas (PCNSL) [miRNA-4]

Project description:miRNA expression data from primary central nervous system lymphomas (PCNSL) [miRNA-4]

| PRJNA637440 | ENA

MicroRNA-138 Suppresses Glioblastoma Proliferation through Downregulation of CD44 (NanoString)

Project description:100 ng of total RNA was processed with the Human v3 miRNA Expression Assay using NanoString nCounter system (NanoString, USA). Expression of individual miRNA was measured by quantitative real-time PCR with TaqMan miRNA Expression kit (Applied Biosystems, Thermo Fisher Scientific, USA).

2021-03-01 | GSE165937 | GEO

Extracellular Vesicle and Particle miRNAs in Maternal Plasma

Project description:EVP miRNAs levels were measured in 54 plasma samples collected approximately 24-28 weeks gestation from individuals in New Hampshire using the NanoString nCounter Human v3 miRNA expression panel

2024-01-31 | GSE223273 | GEO

Circulating microRNAs in association with pancreatic cancer risk within 5 years

Project description:miRNAs levels were measured in plasma samples of pancreatic cancer cases and controls collected within 5 years prior to diagnosis using the NanoString nCounter Human v3 miRNA expression panel

2024-04-01 | GSE262260 | GEO

Whole-genome sequencing of lymphomas in immune-privileged sites

Project description:To characterize the genetic alterations in lymphomas in immune-privileged sites (IP-DLBCLs), we performed whole-genome sequencing (WGS) of 22 primary central nervous system lymphomas (PCNSLs), 8 primary testicular lymphomas (PTLs) and 6 secondary CNS lymphomas.

| EGAS00001005367 | EGA

Extracellular Vesicle and Particle miRNAs in Human Milk

Project description:EVP miRNAs levels were measured in the supernatant fraction of 54 human milk samples collected approximately 6 weeks postpartum from individuals in New Hampshire using the NanoString nCounter Human v3 miRNA expression panel

2024-01-30 | GSE223272 | GEO

Xenograft mouse model to investigate tropism to the CNS and retina in primary central nervous system lymphoma (second batch)

Project description:Primary diffuse large B-cell lymphoma (DLBCL) of the central nervous system (PCNSL) is a rare, extranodal lymphoma. Primary vitreo-retinal lymphoma (PVRL) occurs in 15-25% of PCNSL. CNS involvement also occurs in systemic diffuse large B-cell lymphoma, termed secondary central nervous system lymphoma (SCNSL). Despite intensive treatment, patient outcomes are poor when compared to DLBCL without CNS involvement. How and why lymphoma cells home to the CNS and vitreo-retinal compartment remains unknown. In vivo models to study lymphoma cell tropism are urgently needed. We therefore established and characterized 2 primary and 2 secondary patient-derived CNS lymphoma xenograft mouse models using immunohistochemistry, flow cytometry and nucleic acid sequencing technology. In spleen reimplantation experiments, we characterized the dissemination pattern of orthotopic and heterotopic xenografts and performed RNA sequencing to detect differences on the transcriptome level. Moreover, we found that lymphoma cells in PCNSL xenografts home to the eye after intrasplenal implantation in around 60% of cases, similar to PVRL. This in vivo tumor model preserves key features of this rare lymphoma entity and can be used to explore pathways that are critical for CNS and retinal tropism with the goal to find potential new targets for novel therapeutic approaches .

2023-10-11 | GSE218284 | GEO

Xenograft mouse model to investigate tropism to the CNS and retina in primary central nervous system lymphoma (first batch)

Project description:Primary diffuse large B-cell lymphoma (DLBCL) of the central nervous system (PCNSL) is a rare, extranodal lymphoma. Primary vitreo-retinal lymphoma (PVRL) occurs in 15-25% of PCNSL. CNS involvement also occurs in systemic diffuse large B-cell lymphoma, termed secondary central nervous system lymphoma (SCNSL). Despite intensive treatment, patient outcomes are poor when compared to DLBCL without CNS involvement. How and why lymphoma cells home to the CNS and vitreo-retinal compartment remains unknown. In vivo models to study lymphoma cell tropism are urgently needed. We therefore established and characterized 3 primary and 4 secondary patient-derived CNS lymphoma xenograft mouse models using immunohistochemistry, flow cytometry and nucleic acid sequencing technology. In spleen reimplantation experiments, we characterized the dissemination pattern of orthotopic and heterotopic xenografts and performed RNA sequencing to detect differences on the transcriptome level. Moreover, we found that lymphoma cells in PCNSL xenografts home to the eye after intrasplenal implantation in around 60% of cases, similar to PVRL. This in vivo tumor model preserves key features of this rare lymphoma entity and can be used to explore pathways that are critical for CNS and retinal tropism with the goal to find potential new targets for novel therapeutic approaches .

2023-10-11 | GSE189822 | GEO

Genomic profiling combined with gene expression profiling in primary central nervous system lymphoma

Project description:This SuperSeries is composed of the following subset Series: GSE25297: Genome-wide gene expression comparison (primary central nervous system lymphoma (PCNSL) vs normal lymph node) GSE25298: Genomic aberrations in primary central nervous system lymphoma (PCNSL) Refer to individual Series

2010-11-13 | E-GEOD-25299 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data